Meta Pixel

News and Announcements

Allowance of Phylogica’s US Patent for Synthetic Phylomer Libraries

  • Published October 02, 2013 12:14PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates
  • US Patent allowed for rationally designed synthetic Phylomer libraries
  • Broad applications of synthetic Phylomer libraries in therapeutics and diagnostics
  • Patent allowance further secures Phylogica’s ownership of the entire Phylomer peptide class
  • New patent greatly extends life of Phylogica’s core patent estate – out to November 2027
  • Phylogica is already in discussion with prospective partners interested in accessing this technology

PERTH, AUSTRALIA: October 2nd, 2013 – Phylogica Ltd (ASX: PYC, XETRA: PH7) a leading Australian peptide drug discovery company, announces the allowance of its US patent application for synthetic Phylomer libraries. This core patent (designated USSN 11/672,419) covers generic methods of designing synthetic Phylomer peptide libraries based on the identification of parts of natural proteins, which are predicted to form structures independently when isolated from the parent protein from which they are derived. The patent also contains methods for maximising the diversity of such structures represented in the library.

To read the full ASX Release please click on the document below.

Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy

Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Join over 45,000+ sophisticated investors

Join Now